Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the ...

Health-care companies rose after strong earnings from one obesity-drug maker. Eli Lilly shares rose after it reiterated its forecast for 32% 2025 revenue growth, amid rising demand for its ...

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged ...

U.S. stock futures are edging mostly higher as investors watch corporate earnings, Honeywell plans to split into three companies, and Qualcomm stock drops as its licensing revenue misses expectations.

Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...

Both Qualcomm and Arm Holdings trade lower after earnings, Skyworks says its share of the business to supply Apple will fall ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... in major stock indices such as the S&P 500, Dow Jones Industrial Average, or Nasdaq Composite.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... industry leaders and are included in major stock indices such as the S&P 500, Dow Jones Industrial Average, or ...

Find insight on Siemens Healthineers, WeChat, Apple, U.S. tariffs and more in the latest Market Talks covering Technology, Media and Telecom.

GLP-1 drugs Mounjaro and Zepbound drive a big revenue increase for the drugmaker Eli Lilly & Co. said Thursday ... which is operated by Dow Jones & Co. MarketWatch is published independently ...

But the Dow Jones Industrial Average (^DJI-0.28% ... making it the second most valuable U.S.-based healthcare company behind Eli Lilly. The stock got pummeled in December due to controversy ...